Literature DB >> 17250560

Recipient vascular endothelial growth factor serum levels predict primary lung graft dysfunction.

K Krenn1, W Klepetko, S Taghavi, G Lang, B Schneider, S Aharinejad.   

Abstract

Primary graft dysfunction (PGD) is a severe complication in lung transplantation. Therapeutic strategies are limited and there exist no predictive markers for PGD. To investigate whether vascular endothelial growth factor (VEGF) that regulates vascular permeability could predict PGD, pretransplant VEGF serum concentrations were measured in 150 lung transplant patients and 12 controls by ELISA. PGD was scored from 0 to 3 using chest radiographs and PaO(2)/FiO(2) ratios according to the International Society for Heart and Lung Transplantation guidelines. The mean graft ischemia time was 5 h 47 min and the donors' PaO(2)/FiO(2) ratios were >300. PGD grades 0-3 occurred in 23%, 44%, 21%, and 11% of patients, respectively. Pre-operative VEGF serum concentrations were significantly higher in PGD grade 3 (p < 0.0001) versus grade 0-2 and controls. VEGF concentrations significantly predicted PGD grade 3 versus 0-2 in logistic regression analysis (p < 0.0001) and receiver operating analysis (AUC = 0.778). At a cut-off level of > or =650 pg/mL VEGF had 86% sensitivity and 62% specificity to identify PGD grade 3 versus 0-2. Pre-operative VEGF serum concentrations could identify lung transplant recipients with high PGD risk.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17250560     DOI: 10.1111/j.1600-6143.2006.01673.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  23 in total

1.  VEGF-C alters barrier function of cultured lymphatic endothelial cells through a VEGFR-3-dependent mechanism.

Authors:  Jerome W Breslin; Sarah Y Yuan; Mack H Wu
Journal:  Lymphat Res Biol       Date:  2007       Impact factor: 2.589

2.  Elevated plasma clara cell secretory protein concentration is associated with high-grade primary graft dysfunction.

Authors:  J M Diamond; S M Kawut; D J Lederer; V N Ahya; B Kohl; J Sonett; S M Palmer; M Crespo; K Wille; V N Lama; P D Shah; J Orens; S Bhorade; A Weinacker; E Demissie; S Bellamy; J D Christie; L B Ware
Journal:  Am J Transplant       Date:  2011-02-07       Impact factor: 8.086

3.  Postoperative estradiol levels associate with development of primary graft dysfunction in lung transplantation patients.

Authors:  Julie A Bastarache; Joshua M Diamond; Steven M Kawut; David J Lederer; Lorraine B Ware; Jason D Christie
Journal:  Gend Med       Date:  2012-02-22

4.  Hypoxic Gene Expression of Donor Bronchi Linked to Airway Complications after Lung Transplantation.

Authors:  Bryan D Kraft; Hagir B Suliman; Eli C Colman; Kamran Mahmood; Matthew G Hartwig; Claude A Piantadosi; Scott L Shofer
Journal:  Am J Respir Crit Care Med       Date:  2016-03-01       Impact factor: 21.405

5.  Cell-free hemoglobin promotes primary graft dysfunction through oxidative lung endothelial injury.

Authors:  Ciara M Shaver; Nancy Wickersham; J Brennan McNeil; Hiromasa Nagata; Adam Miller; Stuart R Landstreet; Jamie L Kuck; Joshua M Diamond; David J Lederer; Steven M Kawut; Scott M Palmer; Keith M Wille; Ann Weinacker; Vibha N Lama; Maria M Crespo; Jonathan B Orens; Pali D Shah; Chadi A Hage; Edward Cantu; Mary K Porteous; Gundeep Dhillon; John McDyer; Julie A Bastarache; Jason D Christie; Lorraine B Ware
Journal:  JCI Insight       Date:  2018-01-25

6.  Mitochondrial damage-associated molecular patterns released by lung transplants are associated with primary graft dysfunction.

Authors:  Davide Scozzi; Mohsen Ibrahim; Fuyi Liao; Xue Lin; Hsi-Min Hsiao; Ramsey Hachem; Laneshia K Tague; Alberto Ricci; Hrishikesh S Kulkarni; Howard J Huang; Seiichiro Sugimoto; Alexander S Krupnick; Daniel Kreisel; Andrew E Gelman
Journal:  Am J Transplant       Date:  2019-01-25       Impact factor: 8.086

7.  Impact of prolonged cold preservation on the graft function and gene expression levels in an experimental lung transplantation model.

Authors:  Osamu Yoshida; Masaomi Yamane; Sumiharu Yamamoto; Mikio Okazaki; Shinichi Toyooka; Takahiro Oto; Yoshifumi Sano; Shinichiro Miyoshi
Journal:  Surg Today       Date:  2012-06-27       Impact factor: 2.549

8.  Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction.

Authors:  Jason D Christie; Chirag V Shah; Steven M Kawut; Nilam Mangalmurti; David J Lederer; Joshua R Sonett; Vivek N Ahya; Scott M Palmer; Keith Wille; Vibha Lama; Pali D Shah; Ashish Shah; Ann Weinacker; Clifford S Deutschman; Benjamin A Kohl; Ejigayehu Demissie; Scarlett Bellamy; Lorraine B Ware
Journal:  Am J Respir Crit Care Med       Date:  2009-08-06       Impact factor: 21.405

9.  Genetic variation in the prostaglandin E2 pathway is associated with primary graft dysfunction.

Authors:  Joshua M Diamond; Tatiana Akimova; Altaf Kazi; Rupal J Shah; Edward Cantu; Rui Feng; Matthew H Levine; Steven M Kawut; Nuala J Meyer; James C Lee; Wayne W Hancock; Richard Aplenc; Lorraine B Ware; Scott M Palmer; Sangeeta Bhorade; Vibha N Lama; Ann Weinacker; Jonathan Orens; Keith Wille; Maria Crespo; David J Lederer; Selim Arcasoy; Ejigayehu Demissie; Jason D Christie
Journal:  Am J Respir Crit Care Med       Date:  2014-03-01       Impact factor: 21.405

10.  Elevated donor plasminogen activator inhibitor-1 levels and the risk of primary graft dysfunction.

Authors:  Barbara C S Hamilton; Gabriela R Dincheva; Hanjing Zhuo; Jeffrey A Golden; Marek Brzezinski; Jonathan P Singer; Michael A Matthay; Jasleen Kukreja
Journal:  Clin Transplant       Date:  2018-02-23       Impact factor: 2.863

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.